Publications by authors named "Herman van der Putten"

46Publications

Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na/K ATPase Activity in Dendritic Cells.

Sci Rep 2017 01 25;7:41117. Epub 2017 Jan 25.

Department of Cardiology, Vascular Medicine and Physiology, University of Tübingen, Gmelinstr. 5, D-72076 Tübingen, Germany.

View Article and Find Full Text PDF
January 2017

Bridging NCL research gaps.

Biochim Biophys Acta 2015 Oct 7;1852(10 Pt B):2324-8. Epub 2015 Jun 7.

NCL Foundation, Holstenwall 10, 20355 Hamburg, Germany.

View Article and Find Full Text PDF
October 2015

Leucine-rich repeat kinase 2-sensitive Na+/Ca2+ exchanger activity in dendritic cells.

FASEB J 2015 May 21;29(5):1701-10. Epub 2015 Jan 21.

*Department of Physiology, University of Tübingen, Tübingen, Germany; Department of Neuroscience, Novartis Institutes for BioMedical Research, Basel, Switzerland; Institute of Physiology, University of Zurich, Zurich, Switzerland; National Contest for Life Foundation, Hamburg, Germany; and Department of Pediatric Surgery and Pediatric Urology, University Children's Hospital Tübingen, Tübingen, Germany

View Article and Find Full Text PDF
May 2015

Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse.

Neuropharmacology 2013 Sep 17;72:66-73. Epub 2013 Apr 17.

Department of Anatomy & Neuroscience, University College Cork, Cork, Ireland.

View Article and Find Full Text PDF
September 2013

Opportunities and challenges for molecular chaperone modulation to treat protein-conformational brain diseases.

Neurotherapeutics 2013 Jul;10(3):416-28

Novartis Institutes for BioMedical Research, Novartis Pharma AG, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
July 2013

Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1.

Sci Rep 2012 13;2:262. Epub 2012 Feb 13.

Neuroscience Research, Novartis Institutes for BioMedical Research , Novartis Pharma AG, 4002 Basel, Switzerland.

View Article and Find Full Text PDF
April 2013

The HSP70 molecular chaperone is not beneficial in a mouse model of alpha-synucleinopathy.

PLoS One 2010 Apr 2;5(4):e10014. Epub 2010 Apr 2.

Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.

View Article and Find Full Text PDF
April 2010